title: The new hepatitis C virus bottleneck: Can delaying therapy be justified?
authors.affiliation: Brigham and Women's Hospital, Boston, MA.
authors.forename: Tracey G
authors.initials: TG
authors.lastname: Simon
authors.affiliation: Massachusetts General Hospital, Boston, MA.
authors.forename: Raymond T
authors.initials: RT
authors.lastname: Chung
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000191:economics*; D004334:Drug Administration Schedule; D016527:Drug Costs; D017048:Health Care Costs; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D006278:Medicare / Q000191:economics; D017410:Practice Guidelines as Topic; D013997:Time Factors; D014481:United States
chemical_list: D000998:Antiviral Agents